Author

J. N. Cinatl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Bojkova· 4 shared M. Michaelis· 4 shared M. N. Wass· 4 shared S. Ciesek· 4 shared K.-M. McLaughlin· 3 shared M. Bechtel· 2 shared M. Widera· 2 shared J. E. McGreig· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

D. Bojkova

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

D. Bojkova, M. Widera, S. Ciesek, M. N. Wass, M. Michaelis, J. N. Cinatl

This study compares drug sensitivity and interferon antagonism between Omicron and Delta SARS-CoV-2 variants, finding similar drug responses but reduced interferon antagonism in Omicron.

bioRxiv · Jan 3, 2022Microbiology

CD47 as a potential biomarker for the early diagnosis of severe COVID-19

K.-M. McLaughlin, D. Bojkova, M. Bechtel, J. Kandler, P. Reus, T. Le, J. U. Wagner, S. Ciesek, M. N. Wass, M. Michaelis, J. N. Cinatl

This study identifies CD47 as a potential biomarker for early diagnosis of severe COVID-19 by showing its increased levels in SARS-CoV-2 infection and association with risk factors and complications.

bioRxiv · Mar 1, 2021 · PreprintMicrobiology

COVID-19-related coagulopathy, is transferrin a missing link?

K.-M. McLaughlin, M. Bechtel, D. Bojkova, S. Ciesek, M. N. Wass, M. Michaelis, J. N. Cinatl

The paper identifies transferrin as a potential coagulation promoter in COVID-19, showing age-related increases, sex differences, and upregulation upon infection.

Diagnostics · Jul 30, 2020Peer-reviewedMicrobiology

SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles

D. Bojkova, J. E. McGreig, K.-M. McLaughlin, S. G. Masterson, M. Widera, V. Kraehling, S. Ciesek, M. N. Wass, M. Michaelis, J. N. Cinatl

This study compares SARS-CoV-2 and SARS-CoV in cell tropism and drug sensitivity, finding differences in conservation, receptor usage, and therapeutic responses to aprotinin and remdesivir.

bioRxiv · Apr 3, 2020 · PreprintMicrobiology